Compare UNIT & INVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | UNIT | INVA |
|---|---|---|
| Founded | 2015 | 1996 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Real Estate Investment Trusts | Biotechnology: Pharmaceutical Preparations |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.7B | 1.5B |
| IPO Year | N/A | 2004 |
| Metric | UNIT | INVA |
|---|---|---|
| Price | $8.41 | $20.09 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 4 | 5 |
| Target Price | $6.58 | ★ $36.80 |
| AVG Volume (30 Days) | ★ 2.4M | 625.8K |
| Earning Date | 03-02-2026 | 02-25-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 1036.05 | 53.96 |
| EPS | ★ 8.00 | 1.52 |
| Revenue | ★ $1,610,627,000.00 | $388,521,000.00 |
| Revenue This Year | $97.87 | $13.23 |
| Revenue Next Year | $59.55 | $8.58 |
| P/E Ratio | ★ $1.04 | $13.12 |
| Revenue Growth | ★ 38.94 | 10.14 |
| 52 Week Low | $5.30 | $16.52 |
| 52 Week High | $10.23 | $22.76 |
| Indicator | UNIT | INVA |
|---|---|---|
| Relative Strength Index (RSI) | 70.81 | 56.56 |
| Support Level | $7.08 | $19.47 |
| Resistance Level | $8.02 | $19.90 |
| Average True Range (ATR) | 0.38 | 0.43 |
| MACD | 0.02 | 0.07 |
| Stochastic Oscillator | 86.69 | 95.63 |
Uniti is the product of the August 2025 merger of the firm with Windstream, its former primary customer. The combined firm owns a 217,000 route-mile fiber network that primarily serves enterprise customers. This fiber business generates about 20% of consolidated revenue. Uniti also owns phone networks that reach about 4.5 million households, mostly in less-populated markets in the Southeast. Uniti is rapidly upgrading this network to offer fiber-based broadband services. Its fiber network reaches about 1.8 million locations in its service territory. Residential telecom services account for about a third of total revenue. Small business and wholesale services provided over the legacy phone network account for about 20% of revenue.
Innoviva Inc is a company with a portfolio of royalties healthcare assets. It has three primary sets of assets: a royalty portfolio, operating assets in critical care and infectious disease, and other strategic healthcare assets. Its product offering includes Relvar/Breo/Ellipta, Anoro, Ellipta, Trelegy, Ellipta and others.